4C

CVS Group PLCFRA CVS Group Stock Report

Last reporting period 30 Jun, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

1.097

Small

Exchange

XFRA - Deutsche Boerse AG

4C9.F Stock Analysis

4C

Avoid

Based on Eyestock quantitative analysis, 4C9.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

49/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

18337.6 %

Undervalued

Market cap $B

1.097

Dividend yield

1.59 %

Shares outstanding

71.382 B

CVS Group Plc is a holding company, which engages in the provision of veterinary services. The company is headquartered in Diss, Norfolk and currently employs 7,913 full-time employees. The company went IPO on 2007-10-10. The firm operates veterinary practices, veterinary diagnostic businesses, pet crematoria and an online retail business. CVS is focused on providing clinical services to its customers and their animals. The Company’s segments include Veterinary Practices, Laboratories, Crematoria and Online Retail Business. The Veterinary Practices segment comprises approximately 500 veterinary practices across three markets, including eight specialist referral hospitals and 35 dedicated out-of-hours sites. The Laboratories segment provides diagnostic services and in-practice laboratory analyzers to CVS practices and third-party owned veterinary surgeries. The Company’s Diagnostic services are offered through post and courier allowing a range of coverage of the United Kingdom. The Crematoria segment provides pet cremation and clinical waste disposal for CVS and third-party practices.

View Section: Eyestock Rating